Tart Cherry vs Melatonin: Which Sleep Aid Wins?

One in three adults in the United States and the United Kingdom reports regular trouble sleeping, and two remedies dominate the "natural sleep aid" search results: Montmorency tart cherry juice and melatonin. They are stacked side by side on store shelves as if interchangeable. They are not. One is a hormone your brain already produces; the other is a fruit concentrate containing trace amounts of that hormone plus a separate class of plant compounds. Choosing the wrong one for your specific sleep problem is the most common — and most expensive — mistake.

What the evidence actually says

Melatonin is the better-studied of the two, but its effect sizes are modest. A 2013 meta-analysis of 19 randomised trials, indexed on PubMed, found that supplemental melatonin shortened the time it takes to fall asleep by roughly seven minutes and extended total sleep time by about eight minutes. The NIH Office of Dietary Supplements notes that doses between 0.5 and 5 mg are typical in research, and that lower doses often perform as well as higher ones. The American Academy of Sleep Medicine's 2017 position statement goes further: it does not recommend melatonin as a treatment for chronic insomnia in adults, citing insufficient evidence.

There is also a quality-control problem. A 2017 analysis in the Journal of Clinical Sleep Medicine tested 31 melatonin supplements and found actual content ranging from 83% to 478% of the amount stated on the label; more than a quarter also contained serotonin, a compound with its own risks. In the US, melatonin is sold as a dietary supplement and is not pre-market reviewed by the FDA. In the UK, it is a prescription-only medicine, which the NHS reflects in its guidance.

Tart cherry's evidence base is smaller but not trivial. In a 2012 trial, healthy adults drinking 30 mL of Montmorency cherry concentrate twice daily for seven days increased total sleep time by about 25 minutes and raised urinary levels of 6-sulphatoxymelatonin, the primary melatonin metabolite — suggesting a genuine physiological effect rather than subjective impression. A 2018 pilot study in adults with insomnia reported an average sleep-time gain of roughly 85 minutes after drinking 240 mL of tart cherry juice twice daily, though the sample was small. Montmorency cherries themselves contain measurable melatonin — estimates range from about 0.1 to 13.5 nanograms per gram — alongside anthocyanins that may slow the breakdown of tryptophan, melatonin's biochemical precursor.

Why it matters

The distinction maps directly onto different sleep problems:

• Falling asleep is your issue. Melatonin has the clearer mechanism: taken 30–60 minutes before bed, it shifts circadian timing. This is why it is the better-supported option for jet lag, where guidance from bodies such as the NHS acknowledges its role in resetting the body clock.
• Staying asleep is your issue. Tart cherry's trials showed their largest gains in sleep duration and maintenance, plausibly via anti-inflammatory and tryptophan-sparing pathways rather than a sedative hit.
• Label accuracy matters. With melatonin, the dose you think you are taking may bear little relation to the dose in the bottle. Tart cherry concentrate is a standardised food product, though its sugar content — around 25–30 g per 240 mL of juice — is relevant for anyone managing blood glucose.

There is a cost angle too: a month of quality cherry concentrate typically costs more than a month of melatonin, but you are comparing a food with a supplement whose purity varies widely by manufacturer.

The honest counterpoint

The strongest scientific objection to tart cherry is that its trials are small — usually 20 to 40 participants — short in duration, and several were funded or supplied by cherry industry bodies. The melatonin naturally present in a serving of concentrate is almost certainly too low to act pharmacologically, and critics argue the carbohydrate load or straightforward placebo effects could explain much of the improvement. That objection is legitimate.

The fair response is that melatonin supplements face parallel critiques: small effect sizes, heterogeneous formulations, and documented label inaccuracies, as noted above. Neither remedy is a validated treatment for chronic insomnia. The American College of Physicians and the AASM position cognitive behavioural therapy for insomnia (CBT-I) as first-line care — a point worth stating plainly rather than burying. In my view, tart cherry earns its place as a low-risk, food-based option worth trialling for sleep maintenance, while melatonin earns its place for circadian problems such as jet lag. Both are aids, not treatments.

Does tart cherry juice really contain melatonin?

Yes — Montmorency cherries contain roughly 0.1–13.5 ng/g, though a serving delivers far less than a 0.5 mg supplement, so its effects likely also involve anthocyanins and tryptophan metabolism.

Is melatonin safe to take every night?

Short-term use at 0.5–5 mg appears well tolerated, but long-term safety data are limited and the AASM does not recommend it for chronic insomnia; discuss ongoing use with a clinician.

Which works faster, tart cherry or melatonin?

Melatonin typically acts within 30–60 minutes when taken before bed, while tart cherry's benefits emerged after five to seven days of twice-daily intake in trials.

Sleep problems that persist beyond a few weeks, involve breathing interruptions, or impair daytime function warrant a medical conversation, not a longer supplement shelf. Neither remedy replaces that step.